1. Home
  2. TBBK vs HAE Comparison

TBBK vs HAE Comparison

Compare TBBK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Bancorp Inc

TBBK

The Bancorp Inc

HOLD

Current Price

$69.01

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$79.25

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBBK
HAE
Founded
1999
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.7B
IPO Year
2004
1991

Fundamental Metrics

Financial Performance
Metric
TBBK
HAE
Price
$69.01
$79.25
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$68.00
$84.38
AVG Volume (30 Days)
469.0K
854.6K
Earning Date
01-29-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
21.10
42.54
EPS
4.78
3.44
Revenue
$523,163,000.00
$1,327,850,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$32.53
$6.01
P/E Ratio
$14.38
$24.30
Revenue Growth
10.84
N/A
52 Week Low
$40.51
$47.32
52 Week High
$81.65
$87.32

Technical Indicators

Market Signals
Indicator
TBBK
HAE
Relative Strength Index (RSI) 59.44 56.70
Support Level $65.95 $82.30
Resistance Level $70.95 $87.32
Average True Range (ATR) 1.91 2.21
MACD 0.89 -0.98
Stochastic Oscillator 73.38 5.73

Price Performance

Historical Comparison
TBBK
HAE

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: